6 Hormone Therapy Alternatives During the Estrogen Patch Shortage
If you’ve been reading up on hormone therapy lately, you may have come across headlines about estrogen patch shortages.
Pharmacies running out of stock.
Women driving between CVS locations trying to fill prescriptions.
Monthly scrambles that turn a straightforward treatment into a logistical headache.
For anyone who’s been considering HRT and is now wondering whether it’s worth starting at all, this is a reasonable concern. You don’t want to begin a treatment that you can’t reliably continue.
The good news is that the shortage story, while real, is narrower than the headlines suggest.
What’s Causing the Shortages
Demand for hormone therapy has surged over the past several years. When the FDA removed the black-box warning in late 2025, that surge accelerated. More women are seeking treatment, more providers are comfortable prescribing it, and manufacturers are working to catch up.
Transdermal estradiol patches have been hit hardest. They’re the most popular form of systemic hormone therapy, partly because they bypass the liver and carry a lower risk of blood clots than oral estrogen. Their popularity is also what makes them vulnerable to shortages when demand spikes.
Some women who’ve been stable on patches for years have had to call around to multiple pharmacies or switch to mail-order options just to keep their prescriptions filled.
Why This Shouldn’t Stop You From Starting HRT
Here’s the part the headlines often leave out.
The patch is only one form of hormone therapy, and it’s only one form of transdermal hormone therapy at that.
If you’re considering HRT and worried about whether you’ll be able to get what you need, it helps to know how many options actually exist. The landscape is broader than most women realize.
Transdermal creams. Applied to the skin, absorbed through the tissue, bypassing the liver just like patches do. Similar safety profile, different delivery.
Transdermal gels. Pumped or packeted, rubbed into the skin daily. Widely available and effective.
Transdermal sprays. Applied to the inner forearm. Less commonly prescribed but a legitimate option for women who find other delivery methods inconvenient.
Oral estrogen. Pills remain an option and work well for many women. The cardiovascular considerations are slightly different from transdermal forms, which is something to discuss with your provider, but oral formulations are widely available.
Vaginal estrogen. For women whose primary symptoms are urogenital (dryness, discomfort, recurring UTIs), low-dose vaginal estrogen is highly effective and has a very different safety profile than systemic HRT.
Compounded hormones. In some cases, compounded formulations prepared by specialty pharmacies can fill gaps when commercial products are unavailable. This isn’t the right choice for every woman, but it’s an option your provider can discuss.
The point is that if one form is in short supply, several others are not. Access to hormone therapy doesn’t depend on any single product.
How to Navigate Availability Issues
If you’re starting HRT for the first time, a few practical points are worth keeping in mind.
Ask your provider about more than one delivery method during your initial consultation. Knowing your options ahead of time means you’re not starting from zero if your first choice turns out to be hard to fill.
Consider mail-order pharmacies. Many women who’ve struggled with local availability have had better luck with online or mail-order services. Your prescriptions can be shipped directly to you, often with better reliability than chain pharmacies experiencing regional shortages.
Stay in communication with your provider. If a shortage affects you, there’s almost always a workable alternative. You don’t have to figure it out on your own, and you shouldn’t stop your treatment abruptly while you sort it out.
A Note of Reassurance
If you’ve been holding back on starting hormone therapy because you’ve read scary headlines about shortages, please don’t let that be the reason.
The shortage is a supply issue, not a treatment issue. HRT itself hasn’t become less effective, less safe, or less appropriate for women who are candidates. It’s just that one particular delivery method is temporarily harder to get.
The manufacturers are working to increase production. Pharmacy networks are adapting. And in the meantime, there are multiple paths to the same outcome.
The women I work with who come in worried about whether they’ll actually be able to access treatment usually leave the initial consultation feeling a lot better. Once we talk through the options and what availability looks like for the specific formulations that would work for them, the anxiety eases.
At The A-List Clinic, medications are shipped directly to our patients, which often helps sidestep the pharmacy-level shortages that make headlines. If a particular formulation has limited availability, we work through alternatives together rather than leaving you to figure it out.
If you’ve been waiting to start hormone therapy because you’re unsure whether you can actually get it, that’s a conversation worth having.
